Contact
searchSearch
HMP Global

Advertisement

Advertisement

Advertisement

ADVERTISEMENT

Psoriasis Topic Center

Featured Article

News
Comparing the Cost-Effectiveness of Phototherapy and Biologics for Psoriasis and Atopic Dermatitis Treatment
12/21/2023
"This study is necessary to allow physicians, patients, and health systems to make informed decisions regarding cost-efficacy for a variety of treatment options," said researchers.
"This study is necessary to allow physicians, patients, and health systems to make informed decisions regarding cost-efficacy for a variety of treatment options," said researchers.
"This study is necessary to...
12/21/2023
First Report Managed Care
News
High Rates of Therapy Switching Among Patients With Psoriasis Initiating Biologics
11/06/2023
“Switching was common in psoriasis patients using biologics over 24 months, with the lowest risk of switching observed with IL-23 inhibitors,” said researchers. 
“Switching was common in psoriasis patients using biologics over 24 months, with the lowest risk of switching observed with IL-23 inhibitors,” said researchers. 
“Switching was common in...
11/06/2023
First Report Managed Care
News
Mediterranean Diet Added to Standard Therapy Holds Benefit for Patients with Psoriasis
10/13/2023
A healthy lifestyle that includes maintaining a proper weight, physical activity, and good nutritional choices can positively affect the course of psoriasis, according to a study published online in Nutrients. “Dietary manipulation may not...
A healthy lifestyle that includes maintaining a proper weight, physical activity, and good nutritional choices can positively affect the course of psoriasis, according to a study published online in Nutrients. “Dietary manipulation may not...
A healthy lifestyle that...
10/13/2023
First Report Managed Care
News
AI Revolutionizing Psoriasis Severity Assessment for Precise Therapy and QoL Improvement
09/15/2023
A recent study in the Journal of Medical Internet Research underscores the importance of precise therapy and long-term management for improving the quality of life in psoriasis patients. The study explores the potential benefits of an...
A recent study in the Journal of Medical Internet Research underscores the importance of precise therapy and long-term management for improving the quality of life in psoriasis patients. The study explores the potential benefits of an...
A recent study in the Journal of...
09/15/2023
First Report Managed Care
News
Secukinumab Well-Tolerated in Pediatric Patients With Plaque Psoriasis
08/29/2023
“Secukinumab was equally well tolerated in pediatric patients across age and bodyweight subgroups, and the overall safety profile was consistent with that of adult patients, with no new or unexpected safety signals,” said researchers.
“Secukinumab was equally well tolerated in pediatric patients across age and bodyweight subgroups, and the overall safety profile was consistent with that of adult patients, with no new or unexpected safety signals,” said researchers.
“Secukinumab was equally well...
08/29/2023
First Report Managed Care
News
Interleukin-17 Inhibitors May Improve Psoriasis Symptoms When TNF Inhibitors Do Not
06/08/2023
Switching to an interleukin-17 inhibitor may improve psoriasis symptoms for patients who discontinue a tumor necrosis factor inhibitor due to a lack of response.
Switching to an interleukin-17 inhibitor may improve psoriasis symptoms for patients who discontinue a tumor necrosis factor inhibitor due to a lack of response.
Switching to an interleukin-17...
06/08/2023
First Report Managed Care
News
Global Survey Suggests Patients Have Loose Grasp of Psoriatic Disease
05/16/2023
Many patients with moderate to severe psoriasis lack recognition of common manifestations and comorbidities associated with psoriatic disease, according to new research.
Many patients with moderate to severe psoriasis lack recognition of common manifestations and comorbidities associated with psoriatic disease, according to new research.
Many patients with moderate to...
05/16/2023
First Report Managed Care
News
Three-Year Drug Survival 80% for Ixekizumab in Real-World Patients With Plaque Psoriasis
04/18/2023
The probability of drug withdrawal was higher among patients who had a history of treatment with other biologics, researchers found.
The probability of drug withdrawal was higher among patients who had a history of treatment with other biologics, researchers found.
The probability of drug...
04/18/2023
First Report Managed Care
News
Monoclonal Antibody Effective in Pediatric Patients With Psoriasis
03/07/2023
Researchers found a biologic therapy for psoriasis was safe and effective in pediatric patients and recommended an individualized, holistic approach to treatment. 
Researchers found a biologic therapy for psoriasis was safe and effective in pediatric patients and recommended an individualized, holistic approach to treatment. 
Researchers found a biologic...
03/07/2023
First Report Managed Care
News
Real-World Safety of Treatment in Patients With Psoriasis Appears Comparable to Clinical Trial Reports
10/07/2022
“These results provide evidence that the long-term safety profile of apremilast in psoriasis and psoriatic arthritis in a real-world setting is comparable to that reported in clinical trials and other real-world publications,” researchers...
“These results provide evidence that the long-term safety profile of apremilast in psoriasis and psoriatic arthritis in a real-world setting is comparable to that reported in clinical trials and other real-world publications,” researchers...
“These results provide evidence...
10/07/2022
First Report Managed Care
News
Expert Review Finds Treatment Promising for Pediatric Patients With Plaque Psoriasis
09/23/2022
Study authors examined the safety and efficacy of secukinumab for treating pediatric patients with moderate to severe plaque psoriasis.
Study authors examined the safety and efficacy of secukinumab for treating pediatric patients with moderate to severe plaque psoriasis.
Study authors examined the...
09/23/2022
First Report Managed Care

Newsfeed

News
Comparing the Cost-Effectiveness of Phototherapy and Biologics for Psoriasis and Atopic Dermatitis Treatment
12/21/2023
"This study is necessary to allow physicians, patients, and health systems to make informed decisions regarding cost-efficacy for a variety of treatment options," said researchers.
"This study is necessary to allow physicians, patients, and health systems to make informed decisions regarding cost-efficacy for a variety of treatment options," said researchers.
"This study is necessary to...
12/21/2023
First Report Managed Care
News
High Rates of Therapy Switching Among Patients With Psoriasis Initiating Biologics
11/06/2023
“Switching was common in psoriasis patients using biologics over 24 months, with the lowest risk of switching observed with IL-23 inhibitors,” said researchers. 
“Switching was common in psoriasis patients using biologics over 24 months, with the lowest risk of switching observed with IL-23 inhibitors,” said researchers. 
“Switching was common in...
11/06/2023
First Report Managed Care
News
Mediterranean Diet Added to Standard Therapy Holds Benefit for Patients with Psoriasis
10/13/2023
A healthy lifestyle that includes maintaining a proper weight, physical activity, and good nutritional choices can positively affect the course of psoriasis, according to a study published online in Nutrients. “Dietary manipulation may not...
A healthy lifestyle that includes maintaining a proper weight, physical activity, and good nutritional choices can positively affect the course of psoriasis, according to a study published online in Nutrients. “Dietary manipulation may not...
A healthy lifestyle that...
10/13/2023
First Report Managed Care
News
AI Revolutionizing Psoriasis Severity Assessment for Precise Therapy and QoL Improvement
09/15/2023
A recent study in the Journal of Medical Internet Research underscores the importance of precise therapy and long-term management for improving the quality of life in psoriasis patients. The study explores the potential benefits of an...
A recent study in the Journal of Medical Internet Research underscores the importance of precise therapy and long-term management for improving the quality of life in psoriasis patients. The study explores the potential benefits of an...
A recent study in the Journal of...
09/15/2023
First Report Managed Care
News
Secukinumab Well-Tolerated in Pediatric Patients With Plaque Psoriasis
08/29/2023
“Secukinumab was equally well tolerated in pediatric patients across age and bodyweight subgroups, and the overall safety profile was consistent with that of adult patients, with no new or unexpected safety signals,” said researchers.
“Secukinumab was equally well tolerated in pediatric patients across age and bodyweight subgroups, and the overall safety profile was consistent with that of adult patients, with no new or unexpected safety signals,” said researchers.
“Secukinumab was equally well...
08/29/2023
First Report Managed Care
News
Interleukin-17 Inhibitors May Improve Psoriasis Symptoms When TNF Inhibitors Do Not
06/08/2023
Switching to an interleukin-17 inhibitor may improve psoriasis symptoms for patients who discontinue a tumor necrosis factor inhibitor due to a lack of response.
Switching to an interleukin-17 inhibitor may improve psoriasis symptoms for patients who discontinue a tumor necrosis factor inhibitor due to a lack of response.
Switching to an interleukin-17...
06/08/2023
First Report Managed Care
News
Global Survey Suggests Patients Have Loose Grasp of Psoriatic Disease
05/16/2023
Many patients with moderate to severe psoriasis lack recognition of common manifestations and comorbidities associated with psoriatic disease, according to new research.
Many patients with moderate to severe psoriasis lack recognition of common manifestations and comorbidities associated with psoriatic disease, according to new research.
Many patients with moderate to...
05/16/2023
First Report Managed Care
News
Three-Year Drug Survival 80% for Ixekizumab in Real-World Patients With Plaque Psoriasis
04/18/2023
The probability of drug withdrawal was higher among patients who had a history of treatment with other biologics, researchers found.
The probability of drug withdrawal was higher among patients who had a history of treatment with other biologics, researchers found.
The probability of drug...
04/18/2023
First Report Managed Care
News
Monoclonal Antibody Effective in Pediatric Patients With Psoriasis
03/07/2023
Researchers found a biologic therapy for psoriasis was safe and effective in pediatric patients and recommended an individualized, holistic approach to treatment. 
Researchers found a biologic therapy for psoriasis was safe and effective in pediatric patients and recommended an individualized, holistic approach to treatment. 
Researchers found a biologic...
03/07/2023
First Report Managed Care
News
Real-World Safety of Treatment in Patients With Psoriasis Appears Comparable to Clinical Trial Reports
10/07/2022
“These results provide evidence that the long-term safety profile of apremilast in psoriasis and psoriatic arthritis in a real-world setting is comparable to that reported in clinical trials and other real-world publications,” researchers...
“These results provide evidence that the long-term safety profile of apremilast in psoriasis and psoriatic arthritis in a real-world setting is comparable to that reported in clinical trials and other real-world publications,” researchers...
“These results provide evidence...
10/07/2022
First Report Managed Care
News
Using Deep Learning to Measure MS-Specific Brain Damage Beyond Aging
11/11/2024
A new study published in Neurology aimed to differentiate age-related brain changes from multiple sclerosis (MS)-specific neurodegeneration using MRI.
A new study published in Neurology aimed to differentiate age-related brain changes from multiple sclerosis (MS)-specific neurodegeneration using MRI.
A new study published in...
11/11/2024
First Report Managed Care
News
Adverse Event Data Suggest Selective β1-blockers Pose Asthma Risk
11/11/2024
The risks of asthma and asthma-like adverse events appear to be higher with selective β1-blockers than with nonselective blockers and α- and β-blockers.
The risks of asthma and asthma-like adverse events appear to be higher with selective β1-blockers than with nonselective blockers and α- and β-blockers.
The risks of asthma and...
11/11/2024
First Report Managed Care
News
RNAi Therapies Offer New Hope for Patients With Hereditary Transthyretin Amyloidosis
11/08/2024
RNA interference (RNAi)-based treatments for hereditary transthyretin amyloidosis (ATTR) have shown remarkable promise, offering new hope for patients with this rare but devastating genetic disorder.
RNA interference (RNAi)-based treatments for hereditary transthyretin amyloidosis (ATTR) have shown remarkable promise, offering new hope for patients with this rare but devastating genetic disorder.
RNA interference (RNAi)-based...
11/08/2024
First Report Managed Care
News
Revolutionary Single-Dose Gene Therapy Offers New Hope for Adults with Hemophilia B
11/08/2024
A groundbreaking gene therapy for hemophilia B has shown remarkable success in reducing bleeding episodes and improving the quality of life for adult patients, according to a recent international phase III clinical trial.
A groundbreaking gene therapy for hemophilia B has shown remarkable success in reducing bleeding episodes and improving the quality of life for adult patients, according to a recent international phase III clinical trial.
A groundbreaking gene therapy...
11/08/2024
First Report Managed Care
News
Real-World Evidence Supports Efficacy and Safety of Selexipag in Patients With Pulmonary Arterial Hypertension
11/07/2024
Real-world data shows selexipag effectively improves functional class and risk category outcomes in patients with pulmonary arterial hypertension, regardless of maintenance dose.
Real-world data shows selexipag effectively improves functional class and risk category outcomes in patients with pulmonary arterial hypertension, regardless of maintenance dose.
Real-world data shows selexipag...
11/07/2024
First Report Managed Care
News
Clinical Predictors of One-Year Seizure Freedom After SLAH
11/06/2024
A study published in Annals of Clinical and Translational Neurology aimed to predict 1-year seizure freedom for patients undergoing stereotactic laser amygdalohippocampotomy (SLAH) for mesial temporal lobe epilepsy (MTLE) using a set of...
A study published in Annals of Clinical and Translational Neurology aimed to predict 1-year seizure freedom for patients undergoing stereotactic laser amygdalohippocampotomy (SLAH) for mesial temporal lobe epilepsy (MTLE) using a set of...
A study published in Annals of...
11/06/2024
First Report Managed Care
News
Efficacy and Outcomes of Neoadjuvant Immunotherapy in Lung Cancer
11/05/2024
A meta-analysis of 43 studies suggests that neoadjuvant chemoimmunotherapy may benefit patients with resectable NSCLC and low tumor PD-L1 levels for event-free survival, showing superior outcomes compared to neoadjuvant chemotherapy.
A meta-analysis of 43 studies suggests that neoadjuvant chemoimmunotherapy may benefit patients with resectable NSCLC and low tumor PD-L1 levels for event-free survival, showing superior outcomes compared to neoadjuvant chemotherapy.
A meta-analysis of 43 studies...
11/05/2024
First Report Managed Care
News
FDA Grants Accelerated Approval for Asciminib as First-Line Treatment in Ph+CML-CP
11/01/2024
Novartis received accelerated approval by the US Food and Drug Administration (FDA) for asciminib, a medication for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (Ph+CML-CP).
Novartis received accelerated approval by the US Food and Drug Administration (FDA) for asciminib, a medication for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (Ph+CML-CP).
Novartis received accelerated...
11/01/2024
First Report Managed Care
News
HHS Faces Legal Action From 10 Hospitals Over 2023 Medicare Advantage Rule and Reimbursement Calculations
10/30/2024
Ten hospitals sued the US Department of Health and Human Services (HHS), claiming that they were underpaid Medicare reimbursements for serving low-income patients.
Ten hospitals sued the US Department of Health and Human Services (HHS), claiming that they were underpaid Medicare reimbursements for serving low-income patients.
Ten hospitals sued the US...
10/30/2024
First Report Managed Care
News
Impact of Immune Checkpoint Inhibitors on Multiple Sclerosis Treatment Outcomes
10/29/2024
Relapses and progression of multiple sclerosis were rare in patients treated with immune checkpoint inhibitors, according to a study presented at the American Academy of Neurology 2024 Annual Meeting.
Relapses and progression of multiple sclerosis were rare in patients treated with immune checkpoint inhibitors, according to a study presented at the American Academy of Neurology 2024 Annual Meeting.
Relapses and progression of...
10/29/2024
First Report Managed Care

Advertisement

Insights

Headshot of Jeffrey Stark on a blue background underneath the PopHealth Perspectives logo.
Videos
Psoriasis Treatment Effective at Achieving Skin Clearance
07/26/2021
Jeffrey Stark, MD, head of immunology medical affairs, UCB, breaks down the unique challenges patients with psoriasis face, and discusses the BE RADIANT and BE SURE studies, both of which indicated that bimekizumab was effective at achieving...
Jeffrey Stark, MD, head of immunology medical affairs, UCB, breaks down the unique challenges patients with psoriasis face, and discusses the BE RADIANT and BE SURE studies, both of which indicated that bimekizumab was effective at achieving...
Jeffrey Stark, MD, head of...
07/26/2021
First Report Managed Care
Commentary
Insights Into Selecting Biologics for Psoriasis
07/08/2019
Lawrence Green, MD, associate clinical professor of dermatology at George Washington University School of Medicine, reviews current biologic therapies available for psoriasis and shares his methods for selecting the appropriate biologic for...
Lawrence Green, MD, associate clinical professor of dermatology at George Washington University School of Medicine, reviews current biologic therapies available for psoriasis and shares his methods for selecting the appropriate biologic for...
Lawrence Green, MD, associate...
07/08/2019
First Report Managed Care
Interview
Reviewing the Recently Released Psoriasis Guidelines
03/14/2019
In this discussion, Jeffery Weinberg, MD, medical dermatologist at Mount Sinai School of Medicine, and Megan Noe, MD, MPH, dermatologist at the University of Pennsylvania, highlight the new psoriasis treatment guidelines released by NPF and...
In this discussion, Jeffery Weinberg, MD, medical dermatologist at Mount Sinai School of Medicine, and Megan Noe, MD, MPH, dermatologist at the University of Pennsylvania, highlight the new psoriasis treatment guidelines released by NPF and...
In this discussion, Jeffery...
03/14/2019
First Report Managed Care

Advertisement

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 3

Current Issue

September 2024
Volume 21
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement